Andrew W. Wong
Keine laufenden Positionen mehr
Profil
Mr. Wong joined ProQuest in 2004 as an associate.
His current responsibilities include identifying investment opportunities, conducting due diligence on prospective investments and participating in fundraising.
Prior to joining ProQuest in 2004, Mr. Wong held positions with Lehman Brothers in healthcare equity research and investment banking; with Dendreon Corporation, as senior analyst in business development; and with science/technology advisory firm LifeScience Economics, as senior research associate.
Most recently at Lehman Brothers, he served as a research analyst covering the life science tools and technology sector.
Mr. Wong built and maintained communication flow regarding covered companies with Lehman’s equity traders and institutional sales team, and was also responsible for integrated financial models.
As a Lehman Brothers investment banking associate, Mr. Wong was principally involved in evaluating and executing biotechnology, specialty pharmaceutical, and molecular diagnostic-related M&A and corporate financings.
Mr. Wong received his undergraduate degree, with honors, in Biology with a concentration in immunology from Occidental College and his MBA with majors in Finance and Healthcare Management from The Wharton School, University of Pennsylvania
Ehemalige bekannte Positionen von Andrew W. Wong
| Unternehmen | Position | Ende |
|---|---|---|
ProQuest Management LLC
 ProQuest Management LLC Investment ManagersFinance ProQuest Management LLC (ProQuest Management) is a venture capital firm founded in 1998 by Jay Moorin. The firm headquartered in Naples, Florida. | Private-Equity-Analyst | 18.01.2006 |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Analyst-Equity | 30.12.2003 |
| DENDREON CORPORATION | Corporate Officer/Principal | 30.12.2003 |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Mitglied des Investmentausschusses | - |
Ausbildung von Andrew W. Wong
| Occidental College | Undergraduate Degree |
| University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ProQuest Management LLC
ProQuest Management LLC Investment ManagersFinance ProQuest Management LLC (ProQuest Management) is a venture capital firm founded in 1998 by Jay Moorin. The firm headquartered in Naples, Florida. | Finance |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |